Close

Cantor Fitzgerald Downgrades ContraFect (CFRX) to Neutral, Lowers PT to $1 from $15 Jul 13, 2022 06:18PM
Cantor Fitzgerald Reiterates Overweight Rating. $15 Price Target on ContraFect (CFRX), "Expect Upwards Earnings Revision to Move Share Higher" May 16, 2022 09:49AM
Cantor Fitzgerald Reiterates ContraFect (CFRX) at Overweight with $15 PT, Expects Upwards Earnings Revisions Mar 24, 2022 12:08PM
ContraFect Corporation Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares Mar 22, 2021 04:05PM
ContraFect (CFRX) Prices 10M Share Common Offering at $5/Sh Mar 18, 2021 06:03AM


Mar 17, 2021 11:00PM ContraFect Corporation Prices Public Offering of Common Stock
Mar 17, 2021 04:01PM ContraFect (CFRX) to Offer Common Stock
Mar 17, 2021 04:01PM ContraFect Corporation Announces Proposed Public Offering of Common Stock
Jun 9, 2020 09:23AM Pre-Open Stock Movers 06/09: (NKLA) (LOVE) (M) Higher; (SLNO) (CHK) (CERC) Lower (more...)
Jun 8, 2020 05:06PM After-Hours Stock Movers 6/8: (M) (CFRX) (SMG) HIGHER; (SLNO) (CHK) (CERC) LOWER (more...)
Jun 8, 2020 04:05PM Cantor Fitzgerald Starts ContraFect Corp. (CFRX) at Overweight
May 22, 2020 06:02AM ContraFect (CFRX) Prices 11.797M Share & Warrants Offering at $4.90/Sh
May 21, 2020 10:59PM ContraFect Corporation Prices Approximately $52.5 Million Public Offering of Common Stock and Warrants
May 21, 2020 04:12PM ContraFect (CFRX) Announces Proposed Public Offering of Common Stock and Warrants
May 21, 2020 04:09PM ContraFect Corporation Announces Proposed Public Offering of Common Stock and Warrants
Sep 20, 2018 05:00PM ContraFect to Present at Two Upcoming Investor Conferences
Sep 13, 2017 07:00AM ContraFect to Present at 2017 Cantor Fitzgerald Global Healthcare Conference